Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACS BrightEdge
Boston, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ACS BrightEdge is the American Cancer Society's impact venture fund investing in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and enabling technologies. Investments address critical gaps in cancer care from prevention to survivorship, guided by a proprietary impact assessment framework. As of the end of 2023, the fund had invested $43M in 21 portfolio companies collectively poised to impact millions of patients, but the fund itself does not sponsor individual clinical trials or report clinical results of its own.
- Therapeutic areas
- HematologyOncology
- Modalities
- Small moleculeMonoclonal antibodyCell therapyGene therapyDiagnostic deviceMedical deviceDigital healthVaccineBiologic
- Industry
- Investors
02
Partnerships
Portfolio company syndicates (co-invests with top-tier life sciences/healthcare investors)
Beyond the preview
Go deeper on ACS BrightEdge.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACS BrightEdge.